Stephanie R Mattina
Overview
Explore the profile of Stephanie R Mattina including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
17
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ng S, Mikhail A, Mattina S, Mohammed S, Khan S, Desjardins E, et al.
Mol Metab
. 2024 Nov;
91():102066.
PMID: 39571900
Objective: The molecular mechanisms underlying the maintenance and adaptability of the neuromuscular junction (NMJ) remain poorly understood. This study aimed to investigate the role of AMP-activated protein kinase (AMPK) as...
2.
Vanlieshout T, Stouth D, Raziee R, Sraka A, Masood H, Ng S, et al.
Med Sci Sports Exerc
. 2023 Oct;
56(3):486-498.
PMID: 37882083
Purpose: The purpose of this study was to determine how the intersection of coactivator-associated arginine methyltransferase 1 (CARM1) and biological sex affects skeletal muscle adaptations to chronic physical activity. Methods:...
3.
Mikhail A, Ng S, Mattina S, Ljubicic V
Trends Mol Med
. 2023 Apr;
29(7):512-529.
PMID: 37080889
Duchenne muscular dystrophy (DMD), myotonic dystrophy type 1 (DM1), and spinal muscular atrophy (SMA) are the most prevalent neuromuscular disorders (NMDs) in children and adults. Central to a healthy neuromuscular...
4.
Ng S, Mikhail A, Mattina S, Manta A, Diffey I, Ljubicic V
FASEB J
. 2023 Apr;
37(5):e22863.
PMID: 37016990
Duchenne muscular dystrophy (DMD) is a life-limiting neuromuscular disorder characterized by muscle weakness and wasting. Previous proof-of-concept studies demonstrate that the dystrophic phenotype can be mitigated with the pharmacological stimulation...
5.
Mikhail A, Manta A, Ng S, Osborne A, Mattina S, Mackie M, et al.
Acta Physiol (Oxf)
. 2023 Feb;
237(4):e13943.
PMID: 36726043
Aim: Myotonic dystrophy type 1 (DM1) is the second most common muscular dystrophy after Duchenne and is the most prevalent muscular dystrophy in adults. DM1 patients that participate in aerobic...